Mirang Kim

Itami City Hospital — Japan

Biochemistry, Genetics and Molecular Biology · Life Sciences

29h-index2.4kcitations111works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related gene regulation(36), Epigenetics and DNA Methylation(31), RNA modifications and cancer(28), Lung Cancer Treatments and Mutations(23), Mechanisms of cancer metastasis(12)

Publications111 total

Epigenetic alteration of complement genes in MASLD 2772
The Journal of Immunology·2025Open Access
A case of emergency laparoscopic bilateral salpingo-oophorectomy in an elderly patient with a colostomy
JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY·2025Open Access
Integrative transcriptomic analysis identifies emetine as a promising candidate for overcoming acquired resistance to <scp>ALK</scp> inhibitors in lung cancer
Molecular Oncology·2024· 2 citedOpen Access
Correspondence to editorial on “DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease”
Clinical and Molecular Hepatology·2024Open Access
Author response for "Integrative transcriptomic analysis identifies emetine as a promising candidate for overcoming acquired resistance to &lt;scp&gt;ALK&lt;/scp&gt; inhibitors in lung cancer"
2024
Author response for "Integrative transcriptomic analysis identifies emetine as a promising candidate for overcoming acquired resistance to &lt;scp&gt;ALK&lt;/scp&gt; inhibitors in lung cancer"
2024
DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease
Clinical and Molecular Hepatology·2024· 9 citedOpen Access
Author response for "Integrative transcriptomic analysis identifies emetine as a promising candidate for overcoming acquired resistance to &lt;scp&gt;ALK&lt;/scp&gt; inhibitors in lung cancer"
2024
Abstract 2110: Reprogramming of DNA methylation in NAFLD progression
Cancer Research·2023
Supplementary figure legends from Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors
2023Open Access
Table S3 from Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors
2023Open Access
Data from Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors
2023Open Access
Table S2 from Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors
2023Open Access
Table S3 from Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors
2023Open Access
Supplemental figure S1, S2, S3, S4, S5, S6 from Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors
2023Open Access
Data from Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors
2023Open Access
Table S1 from Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors
2023Open Access
Supplementary figure legends from Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors
2023Open Access
Supplementary Materials and Methods from Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors
2023Open Access
Table S2 from Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Seon‐Young Kim(27), Yong‐Sung Kim(15), Yong Sung Kim(14), Seung‐Moo Noh(13), Kyu‐Sang Song(13), Jong‐Lyul Park(9), Hyang‐Sook Yoo(8), Jeong‐Hwan Kim(8), Keeok Haam(8), Hee‐Jin Kim(7), Kyu Sang Song(7), Tae-Wook Kang(6), Jong-Hwan Kim(5), Jeong‐Hwan Kim(5), Hyun Yong Jeong(5), Haejeong Heo(5), Seung-Kyoon Kim(4), Dongsup Kim(4), Daeyoup Lee(4), Hay-Ran Jang(4)